TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $502M (100.0% shares, 0.0% debt)

Holdings (16)

HRTX HERON THERAPEUTICS INC 24.4%

Value $123M Shares 7,907,087 Est. Cost $15.91 Unrealized 0.0%

RCKT ROCKET PHARMACEUTICALS INC 22.3%

Value $112M Shares 2,531,800 Est. Cost $16.31 Unrealized +166.3%

ANAB ANAPTYSBIO INC 13.6%

Value $68.16M Shares 2,628,678 Est. Cost $21.51 Unrealized +11.4%

— ODONATE THERAPEUTICS INC 10.8%

Value $54.15M Shares 15,514,566 Est. Cost $24.10 Unrealized —

— LA JOLLA PHARMACEUTICAL CO 8.6%

Value $43.01M Shares 10,049,224 Est. Cost $9.96 Unrealized —

— APTEVO THERAPEUTICS INC 7.9%

Value $39.48M Shares 1,760,000 Est. Cost $36.65 Unrealized —

— VINCERX PHARMA INC 2.7%

Value $13.39M Shares 1,030,634 Est. Cost $16.05 Unrealized —

CHRS COHERUS BIOSCIENCES INC 1.8%

Value $8.99M Shares 650,000 Est. Cost $17.90 Unrealized -20.9%

ALT ALTIMMUNE INC 1.5%

Value $7.717M Shares 783,407 Est. Cost $13.67 Unrealized 0.0%

— CHEMOCENTRYX INC 1.3%

Value $6.695M Shares 500,000 Est. Cost $13.39 Unrealized —

RVPH REVIVA PHARMACEUTCLS HLDGS I 1.2%

Value $5.832M Shares 1,200,000 Est. Cost $5.04 Unrealized 0.0%

— ITEOS THERAPEUTICS INC 1.1%

Value $5.628M Shares 219,396 Est. Cost $25.65 Unrealized —

— BCTG ACQUISITION CORP 1.1%

Value $5.334M Shares 468,750 Est. Cost $10.36 Unrealized —

EQ EQUILLIUM INC 0.7%

Value $3.534M Shares 600,000 Est. Cost $5.23 Unrealized +20.6%

RLMD RELMADA THERAPEUTICS INC 0.6%

Value $3.201M Shares 100,000 Est. Cost $28.22 Unrealized +23.1%

— NEXTCURE INC 0.5%

Value $2.409M Shares 300,000 Est. Cost $8.03 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	7,907,087	$123M	24.4%	$15.91	0.0%	COM	427746102
RCKT	ROCKET PHARMACEUTICALS INC	2,531,800	$112M	22.3%	$16.31	+166.3%	COM	77313F106
ANAB	ANAPTYSBIO INC	2,628,678	$68.16M	13.6%	$21.51	+11.4%	COM	032724106
—	ODONATE THERAPEUTICS INC	15,514,566	$54.15M	10.8%	$24.10	—	COM	676079106
—	LA JOLLA PHARMACEUTICAL CO	10,049,224	$43.01M	8.6%	$9.96	—	COM	503459604
—	APTEVO THERAPEUTICS INC	1,760,000	$39.48M	7.9%	$36.65	—	COM NEW	03835L207
—	VINCERX PHARMA INC	1,030,634	$13.39M	2.7%	$16.05	—	COM NEW	92731L106
CHRS	COHERUS BIOSCIENCES INC	650,000	$8.99M	1.8%	$17.90	-20.9%	COM	19249H103
ALT	ALTIMMUNE INC	783,407	$7.717M	1.5%	$13.67	0.0%	COM NEW	02155H200
—	CHEMOCENTRYX INC	500,000	$6.695M	1.3%	$13.39	—	COM	16383L106
RVPH	REVIVA PHARMACEUTCLS HLDGS I	1,200,000	$5.832M	1.2%	$5.04	0.0%	COM	76152G100
—	ITEOS THERAPEUTICS INC	219,396	$5.628M	1.1%	$25.65	—	COM	46565G104
—	BCTG ACQUISITION CORP	468,750	$5.334M	1.1%	$10.36	—	COM	05492W103
EQ	EQUILLIUM INC	600,000	$3.534M	0.7%	$5.23	+20.6%	COM	29446K106
RLMD	RELMADA THERAPEUTICS INC	100,000	$3.201M	0.6%	$28.22	+23.1%	COM	75955J402
—	NEXTCURE INC	300,000	$2.409M	0.5%	$8.03	—	COM	65343E108